Ask a smoker to list what smoking damages and you will get lungs, heart, circulation, skin, teeth. Eyes appear on almost nobody's list. Yet smoking is among the strongest modifiable risk factors for two of the leading causes of sight loss, and the size of the effect surprises people who thought they knew the risks.
The mechanism is not mysterious once you consider what the eye is. The retina has one of the highest metabolic rates of any tissue in the body and depends on a dense, extremely fine network of blood vessels to supply it. Anything that damages small vessels, reduces oxygen delivery and raises oxidative stress hits it hard. Smoking does all three at once. Carbon monoxide displaces oxygen in the blood; the chemicals in smoke damage vessel linings and promote inflammation; and the antioxidant defences that protect the retina are depleted.
Age-related macular degeneration is the clearest case. It destroys central vision — the part you read and recognise faces with — and it is a leading cause of sight loss in older adults. Smokers are substantially more likely to develop it, with studies commonly reporting risk two to four times that of non-smokers, and they tend to develop it earlier. Among the risk factors for macular degeneration, age and genetics cannot be changed. Smoking can.
Cataracts are the second. The lens clouds with age in most people eventually, but smoking accelerates it, and the relationship scales with how much you have smoked. Cataract surgery is common and effective, which leads people to shrug at this one, but it is still an operation, and it arrives sooner.
Need help right now?
If a craving feels strong, send a support request and we’ll connect you with an available supporter.
There are several less famous effects worth knowing. Smoking is associated with dry eye, which is more than an irritation when it is persistent. In people with diabetes it worsens diabetic retinopathy, compounding damage to the same small vessels from two directions. It is a major risk factor for thyroid eye disease in people with Graves' disease, where the effect is large and quitting meaningfully changes the course. And there is an increased risk of optic neuropathy, which is rarer but permanent.
Then the part that matters if you are quitting: how much of this reverses.
The vascular and inflammatory contributions improve after stopping, in the same way they do elsewhere in the body, and the risk of macular degeneration falls over time in former smokers. It does not drop immediately and it takes years rather than months to approach that of someone who never smoked — long-term ex-smokers land much closer to never-smokers than to current smokers. Cataract progression slows. Dry eye tends to improve. Thyroid eye disease responds particularly well, which is why ophthalmologists are emphatic about quitting in that group specifically.
What does not reverse is damage already done. Vision lost to macular degeneration does not return, and a clouded lens does not clear. This is one of those areas where the argument for stopping is not about undoing the past but about how much of the future is still available, and where the earlier you stop the more of it there is.
Two practical notes. If you smoke and you are over fifty, an eye test that includes a retinal examination is worth having even if your vision seems fine, because early macular degeneration is often asymptomatic and there are things worth knowing sooner. And be careful with high-dose beta-carotene supplements marketed for eye health: trials found an increased risk of lung cancer in smokers taking them, and eye-health formulations are made in versions specifically without it for that reason. If you are buying something for your eyes and you smoke, read the label.